Manufacturers Life Insurance Company, The Moon Lake Immunotherapeutics Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 142,702 shares of MLTX stock, worth $6.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
142,702
Previous 118,126
20.8%
Holding current value
$6.11 Million
Previous $5.96 Million
27.34%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding MLTX
# of Institutions
136Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$846 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$364 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$143 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$119 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$93.7 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.58B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...